Provided by Tiger Fintech (Singapore) Pte. Ltd.

AEON Biopharma

0.4580
-0.0219-4.56%
Post-market: 0.46000.0020+0.44%19:32 EDT
Volume:198.16K
Turnover:90.58K
Market Cap:4.82M
PE:0.01
High:0.4792
Open:0.4700
Low:0.4300
Close:0.4799
Loading ...
Aug 06, 2024

Major Issues Report

Form 8-K - Current report
Aug 02, 2024

Correspondence

Form CORRESP - Correspondence
Jul 29, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 23, 2024

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Jul 23, 2024

Correspondence

Form CORRESP - Correspondence
Jul 09, 2024

Correspondence

Form CORRESP - Correspondence
Jul 09, 2024

Major Issues Report

Form 8-K - Current report
Jun 14, 2024

Major Issues Report

Form 8-K - Current report
May 31, 2024

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
May 31, 2024

Correspondence

Form CORRESP - Correspondence
May 16, 2024

Major Issues Report

Form 8-K - Current report
May 14, 2024

[Rev.]Annual Report

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
May 14, 2024

Major Issues Report

Form 8-K - Current report
May 14, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 24, 2023

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Nov 13, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 13, 2023

Major Issues Report

Form 8-K - Current report
Oct 23, 2023

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Oct 19, 2023

Major Issues Report

Form 8-K - Current report
Oct 03, 2023

Major Issues Report

Form 8-K - Current report